Harmony Biosciences Holdings, Inc. (HRMY): Total Assets
$1.27B
As of 2025-12-31
$1.37B
As of 2026-06-30
+23.6%
3-year compound annual growth
+24.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.27B | +27.3% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $999.20M | +23.1% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $811.45M | +20.4% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $673.87M | +55.5% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $433.44M | +1.5% | 2023-02-21, Balance as of period end |
| 2020-12-31 | $427.07M | +300.2% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $106.70M | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $1.27B | +27.3% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.44B | +12.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $1.39B | +21.5% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.52B | +17.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.66B | -0.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $836.65M | -0.5% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $1.32B | -5.1% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $1.26B | -18.6% |
Compare HRMY, ANIP, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗